Halloween Special Mouse&human Chimeric Integrin Alpha V Beta 6 (itgav&itgb6) Heterodimer Protein, Ultra Low Endotoxin (itg-hm1v6-ul) Limited Time 45% Off [O4K58zTx]

Mouse & Human Chimeric Integrin alpha V beta 6 Heterodimer

The Mouse & Human Chimeric Integrin alpha V beta 6 (ITGAV&ITGB6) Heterodimer Protein, Ultra Low Endotoxin (ITG-HM1V6-UL) is a cutting-edge research tool designed for scientists in the fields of immunology, cell biology, and oncology. This high-purity protein is a chimeric heterodimer, offering the unique combination of mouse and human integrins alpha V and beta 6. The ultra-low endotoxin level ensures reliable and reproducible experimental results, making it an essential component for various research applications.

• Chimeric design for enhanced functionality
• Ultra-low endotoxin content for reliable results
• High purity and stability for consistent performance

Product Properties and Specifications

Our ITG-HM1V6-UL is produced through a proprietary expression system, ensuring optimal protein expression and functionality. The heterodimer is available in a lyophilized form, allowing for convenient storage and reconstitution. The protein is characterized by a molecular weight of approximately 180 kDa and contains both mouse and human integrin domains. Each lot is rigorously tested for purity, activity, and endotoxin levels to meet the highest quality standards.

• Lyophilized for easy storage and reconstitution
• High purity and activity confirmed by SDS-PAGE and ELISA
• Endotoxin level below 0.1 EU/mg to ensure reproducibility

Applications and Benefits

The Mouse & Human Chimeric Integrin alpha V beta 6 Heterodimer Protein, Ultra Low Endotoxin (ITG-HM1V6-UL) is widely used in various research applications, including cell adhesion assays, signaling pathway studies, and drug discovery. Its versatility makes it an ideal tool for both basic research and translational studies. By using this protein, researchers can explore the complex interactions between integrins and their ligands, leading to a better understanding of disease mechanisms and potential therapeutic targets.

• Enables detailed studies of cell adhesion and signaling pathways
• Facilitates drug discovery and development in oncology and immunology
• Supports translational research and clinical applications